Outcome
Consolidated documentation: Produced validation documentation and an inclusive technical file for the client to progress straight towards regulatory submission.
Software issues resolved: Data analytics meant informed design decisions were made quickly resolving software issues.
Reduced development timelines: Accelerated the design and development process achieving a prototype 3 months before the deadline.
CHALLENGE
- Developing a testing strategy
- Specific in-house expertise
- Operating within budget
- Project time constraints
Remote blood cell counting device to transform chemotherapy patient support
Many patients undergoing chemotherapy treatment, roughly 10.5%, experience complications that lead to emergency admissions. Monitoring patients at home could mean early identification of risks leading to potentially life-saving interventions. Patients could also avoid being called into hospital unnecessarily therefore improving hospital efficacy.
This health company is transforming the way chemotherapy patients are supported, whilst empowering them to be actively involved in the monitoring of their well-being at home. Providing a home remote blood cell counting device, as part of a wider end-to-end patient monitoring service, means oncologists have regular access to patients' well-being. Using this self-test information obtained at the patient's home avoids missing key symptoms and allows for early intervention.
